1 – 10 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer: comparing the definitions of CHAARTED and LATITUDE trial
- Abscopal effect in metastatic renal cell carcinoma
- Which factors predict overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post-docetaxel?
- CD70 and PD-L1 in anaplastic thyroid cancer-promising targets for immunotherapy
- Neither creatinine nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents
- Prognostic markers in oropharyngeal squamous cell carcinoma : focus on CD70 and tumour infiltrating lymphocytes
- Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile
- Checkpoint inhibition : new treatment options in urologic cancer
- The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies
- Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer